Rezolute (RZLT) Prepaid Assets (2011 - 2026)
Rezolute recorded quarterly Prepaid Assets of $1.8 million in Q1 2026, down 17.85% quarter-over-quarter from $2.2 million in Q4 2025, and down 3.36% year-over-year from $1.8 million in Q1 2025.
Rezolute's Prepaid Assets history runs 16 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 3.36% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (down 3.36% YoY), while the FY2025 annual figure was $3.3 million, up 84.77% from the prior year.
- Prepaid Assets came in at $1.8 million for Q1 2026 at Rezolute, down from $2.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.9 million in Q3 2023 to a low of $860000.0 in Q4 2022.
- A 5-year average of $2.2 million and a median of $2.2 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 344.17% in 2022 and plunged 51.34% in 2024, its largest moves.
- Rezolute's Prepaid Assets stood at $860000.0 in 2022, then surged by 305.47% to $3.5 million in 2023, then slumped by 38.23% to $2.2 million in 2024, then advanced by 0.65% to $2.2 million in 2025, then decreased by 17.85% to $1.8 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.8 million, $2.2 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 2.17 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Jun 30, 2025 | 3.29 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 2.19 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Sep 30, 2023 | 3.92 Mn |
| Jun 30, 2023 | 3.01 Mn |
| Mar 31, 2023 | 2.46 Mn |
| Dec 31, 2022 | 860,000.00 |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 915,000.00 |
| Dec 31, 2021 | 695,000.00 |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 946,000.00 |
| Mar 31, 2021 | 206,000.00 |
| Dec 31, 2020 | 554,000.00 |
| Sep 30, 2020 | 491,000.00 |
| Jun 30, 2020 | 563,000.00 |
| Mar 31, 2020 | 133,000.00 |
| Dec 31, 2019 | 257,000.00 |
| Sep 30, 2019 | 454,000.00 |
| Jun 30, 2019 | 571,000.00 |
| Mar 31, 2019 | 13,992.00 |
| Dec 31, 2018 | 91,553.00 |
| Sep 30, 2018 | 372,114.00 |
| Jun 30, 2018 | 362,000.00 |
| Mar 31, 2018 | 367,810.00 |
| Dec 31, 2017 | 295,728.00 |
| Sep 30, 2017 | 349,170.00 |
| Jun 30, 2017 | 442,015.00 |
| Mar 31, 2017 | 413,037.00 |
| Dec 31, 2016 | 213,441.00 |
| Sep 30, 2016 | 363,799.00 |
| Jun 30, 2016 | 430,094.00 |
| Mar 31, 2016 | 294,278.00 |
| Dec 31, 2015 | 134,773.00 |
| Sep 30, 2015 | 64,671.00 |
| Jun 30, 2015 | 387,511.00 |
| Mar 31, 2015 | 175,023.00 |
| Dec 31, 2014 | 66,789.00 |
| Sep 30, 2014 | 95,877.00 |
| Jun 30, 2014 | 83,425.00 |
| Mar 31, 2014 | 119,800.00 |
| Dec 31, 2013 | 13,969.00 |
| Sep 30, 2013 | 50,218.00 |
| Jun 30, 2013 | 95,469.00 |
| Mar 31, 2013 | 369,741.00 |
| Jun 30, 2012 | 102,175.00 |
| Dec 31, 2011 | 100,000.00 |